Table 1.
Question | China | Hong Kong | Singapore | South Korea | Thailand | Azerbaijan | Albania | Greece | Netherland | Morocco | Oman | Sudan | Costa Rica | Canada | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Included in SRS | Y | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | N | N | Y | ||
Type of H&TM | RA-approved PP | Y | Y | Y | Y | Y | Y | NA | Y | Y | Y | Y | NA | NA | Y | |
Raw materials | N | Y | Y | Y | Y | Y | NA | N | Y | Y | Y | NA | NA | Y | ||
Medicines prepared at MIs | N | N | N | Y | N | N | NA | N | Y | Y | Y | NA | NA | Y | ||
The others | N | N | N | Y | N | N | NA | N | Y | Y | Y | NA | NA | Y |
SRS: spontaneous adverse event reporting system, Y: yes, N: no, H&TM: herbal & traditional medicine, RA: regulatory authorities, PP: pharmaceutical products, MI: medical Institutions, NA: not answered.